A. Berent

INCREASE IN LEG BLOOD-FLOW BY NORMOVOLÆMIC HÆMODDLUTION IN INTERMITTENT CLAUDICATION

J. Dormandy, C. Yates, Vivienne Andrews, 1979, The Lancet.

The use of the selective serotonin S2 receptor antagonist Ketanserin in the treatment of Raynaud's phenomenon.

J. Dormandy, S. Downes, A. Berent, 1988, European journal of vascular surgery.

PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO-CENTRE TRIAL OF KETANSERIN IN INTERMITTENT CLAUDICATION

R. Verhaeghe, H. Bounameaux, H. Hellemans, 1985, The Lancet.

ACVIM Small Animal Consensus Recommendations on the Treatment and Prevention of Uroliths in Dogs and Cats

J. Bartges, J. Lulich, C. Osborne, 2019 .